>Conference call feedback: 2024 guidance confirmed but no indication on medium-term prospects after the abandonment (unsurprisingly) of the 2025 targets - CompuGroup published yesterday morning a soft Q1 2024, slightly below expectations (first take link published yesterday). Below are the main elements from the conference call: 1/ 2024 guidance confirmed with a more favourable base effect in H2. As anticipated, the momentum in H1 has been penalised by the base effec...
>Feedback conf. call : guidance 2024 confirmée mais aucune indication sur les perspectives MT après l’abandon (sans surprise) des objectifs 2025 - CompuGroup a publié hier matin un T1 2024 soft et légèrement en deçà des attentes (lien first take publiée hier). Ci-dessous les principaux éléments que nous retenons de la conférence call : 1/ Guidance 2024 confirmée avec un effet de base plus favorable au S2. Comme anticipé, la dynamique du S1 est pénalisée par l’effet d...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
Unifiedpost is a niche SaaS player in the e-invoicing and procurement channel space. Regulatory headwinds mean this market is ripe for growth, which should benefit Unifiedpost. Due to some unsuccessful past M&A, the company is in a challenging financial position today. However, it has recently embarked on a divestment path, aiming to streamline the business and improve its fundamentals. We like the new direction, however prefer to take a wait-and-see approach. - ...
>Q1 2024 slightly below expectations - This morning, CompuGroup published its Q1 2024 results, which came in a slightly below expectations. Q1 revenues were down 2% y-o-y to € 285m (-1% vs css). Excluding the TI effect, organic growth was up 3%. By division, HIS continued to drive growth in Q1 with revenues up 7% y-o-y to € 78m (-2% vs the consensus) mainly thanks to the ramp-up of the Hospital Future Act programme in Germany. On the other hand, the performance by AIS...
>Q1 2024 slightly below expectations - This morning, CompuGroup published its Q1 2024 results, which came in a slightly below expectations. Q1 revenues were down 2% y-o-y to € 285m (-1% vs css). Excluding the TI effect, organic growth was up 3%. By division, HIS continued to drive growth in Q1 with revenues up 7% y-o-y to € 78m (-2% vs the consensus) mainly thanks to the ramp-up of the Hospital Future Act programme in Germany. On the other hand, the performance by AIS...
EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Quarter Results/Quarterly / Interim Statement CompuGroup Medical with solid first quarter against strong prior year 08.05.2024 / 07:07 CET/CEST The issuer is solely responsible for the content of this announcement. CompuGroup Medical with solid first quarter against strong prior year Revenues down by 2%, organic growth of 3% adjusted for TI one-offs Recurring revenue share increases to 75% Advancing digitization in German and French healthcare Continuing revenue conversion of hospital order backlog Leverage r...
EQS-News: CompuGroup Medical SE & Co. KGaA / Schlagwort(e): Quartalsergebnis/Quartals-/Zwischenmitteilung CompuGroup Medical mit solidem ersten Quartal gegenüber starkem Vorjahreszeitraum 08.05.2024 / 07:07 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CompuGroup Medical mit solidem ersten Quartal gegenüber starkem Vorjahreszeitraum Umsatzrückgang um 2 %, organisches Wachstum bereinigt um TI-Einmaleffekte bei 3 % Anteil der wiederkehrenden Umsätze steigt auf 75 % Fortschreitende Digitalisierung im deutschen und französischen Gesu...
>Top and bottom line below expectations - Q1 revenues came in 2% lower at € 32.8m (-24% vs cs) with product sales stable at € 32.1m (-21% vs cs). This disappointing performance can mainly be attributed to supply issue for Ixiaro which showed a decline of 5% (-34% vs cs). Dukoral saw sales grow by 10% to € 11.3m (+18% vs cs) underpinned by a recovery in the traveller market. As expected, third-party distribution (-9%, -33% vs Cs) suffered from supply constraints for t...
>Strong Q1 2024 results - This morning, Elmos reported Q1 2024 results that beat expectations. Revenues were € 136.8m, above the consensus at € 135.4m. They were up 4.5% y-o-y but down 13% q-o-q. EBIT came in at € 33.8m, giving an EBIT margin of 24.7% above the consensus at € 31.7m and 23.4%. EPS was € 1.44 above consensus at € 1.27. Adjusted free cash flow stood at -€ 48.9m (vs € 35m in Q4 2023) impacted by year-end effects on working capital. Capex came in at € 20.3...
>Strong Q1 2024 results - This morning, Elmos reported Q1 2024 results that beat expectations. Revenues were € 136.8m, above the consensus at € 135.4m. They were up 4.5% y-o-y but down 13% q-o-q. EBIT came in at € 33.8m, giving an EBIT margin of 24.7% above the consensus at € 31.7m and 23.4%. EPS was € 1.44 above consensus at € 1.27. Adjusted free cash flow stood at -€ 48.9m (vs € 35m in Q4 2023) impacted by year-end effects on working capital. Capex came in at € 20.3...
Valneva reported its Q1 2024 results where revenues came in at EUR 32.8m (vs css EUR 43.1m), including product sales of EUR 32.1m, driven by Ixiaro (EUR 16.6m, -4.8%), Dukoral (EUR 11.3m, +10.3%), and third party products (EUR 4.1m, -8.9%). The decrease in Ixiaro sales is mainly attributed by the s
>En dessous de attentes en topline et bottom line - Les revenus T1 sont en baisse de 2% à 32.8 M€ (-24% vs css) avec des ventes de produits stables à 32.1 M€ (-21% vs css). Cette performance décevante s’explique principalement par des problèmes d'approvisionnement sur Ixiaro qui ressort en baisse de 5% (-34% vs css). Dukoral affiche une croissance de 10% à 11.3 M€ (+18% vs css) soutenue par la reprise du marché du voyageur. Comme prévu, la distribution pour tiers (-9%...
EQS-News: Elmos Semiconductor SE / Key word(s): Quarter Results Elmos: Positive start into the new fiscal year – guidance for 2024 confirmed 07.05.2024 / 07:40 CET/CEST The issuer is solely responsible for the content of this announcement. Sales up by 4.5% to 136.8 million Euro in the first quarter of 2024 – EBIT margin reaches 24.7% Dortmund, May 7, 2024: Elmos Semiconductor SE (FSE: ELG) has made a positive start into the new fiscal year and generated Group sales of 136.8 million Euro in the first quarter of 2024, representing sales growth of 4.5% year on year (Q1 2023...
EQS-News: Elmos Semiconductor SE / Schlagwort(e): Quartalsergebnis Elmos: Positiver Start in das neue Geschäftsjahr – Prognose 2024 bestätigt 07.05.2024 / 07:40 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Umsatz steigt im ersten Quartal 2024 um 4,5% auf 136,8 Mio. Euro – EBIT-Marge erreicht 24,7% Dortmund, 7. Mai 2024: Die Elmos Semiconductor SE (FSE: ELG) ist positiv in das neue Geschäftsjahr gestartet und erzielte im ersten Quartal 2024 mit einem Konzernumsatz von 136,8 Mio. Euro ein Umsatzwachstum von 4,5% gegenüber dem Vorjah...
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1 million, on track to meet anticipated full year guidance Cash position of €176.6 million, including €95 million from sale of Priority Review Voucher (PRV)1. Significantly extended cash runway with recent update of debt financing agreement2Substantially lower cash burn expected in 2024 as Valneva expects to complete...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.